NASDAQ:TLMD

SOC Telemed Stock Forecast, Price & News

$7.96

+0.40 (+5.29 %)

(As of 01/22/2021 12:00 AM ET)

Add

Compare

Today's Range

$7.32

Now: $7.96▼

$8.10

50-Day Range

$6.81

MA: $7.66▼

$8.56

52-Week Range

$6.75

Now: $7.96▼

$12.08

Volume493,988 shs

Average Volume463,463 shs

Market Capitalization$713.41 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

SOC Telemed, Inc. provides telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePsychiatry, and teleICU. The company was founded in 2004 and is based in Reston, Virginia.

Overall MarketRank^™

1.60 out of 5 stars

Medical Sector

303rd out of 1,925 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

3rd out of 25 stocks

3.4 Analyst's Opinion

Consensus Rating
SOC Telemed has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $12.00, SOC Telemed has a forecasted upside of 50.8% from its current price of $7.96.
Amount of Analyst Coverage
SOC Telemed has only been the subject of 4 research reports in the past 90 days.

4.0 Community Rank

Outperform Votes
SOC Telemed has received 4 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
SOC Telemed has received 1 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
SOC Telemed has received 80.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about SOC Telemed and other stocks. Vote “Outperform” if you believe TLMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TLMD will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
SOC Telemed does not currently pay a dividend.
Dividend Growth
SOC Telemed does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SOC Telemed insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 20.70% of the stock of SOC Telemed is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for SOC Telemed are expected to grow in the coming year, from ($0.39) to ($0.23) per share.
Price to Book Value per Share Ratio
SOC Telemed has a P/B Ratio of 13.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Miscellaneous health & allied services, not elsewhere classified

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:TLMD

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.soctelemed.com

Phone703-678-2122

Employees287

Debt

Debt-to-Equity RatioN/A

Current Ratio0.24

Quick Ratio0.24

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash Flow$0.00 per share

Price / Cash Flow2,571.92

Book Value$0.61 per share

Price / Book13.05

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares89,624,000

Market Cap$713.41 million

Next Earnings Date2/15/2021 (Estimated)

OptionableOptionable

$7.96

+0.40 (+5.29 %)

(As of 01/22/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive TLMD News and Ratings via Email

Sign-up to receive the latest news and ratings for TLMD and its competitors with MarketBeat's FREE daily newsletter.

SOC Telemed (NASDAQ:TLMD) Frequently Asked Questions

Is SOC Telemed a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SOC Telemed in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SOC Telemed stock.
View analyst ratings for SOC Telemed or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than SOC Telemed?

Wall Street analysts have given SOC Telemed a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SOC Telemed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as SOC Telemed's CEO?

1,448 employees have rated SOC Telemed CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among SOC Telemed's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is SOC Telemed's next earnings date?

SOC Telemed is scheduled to release its next quarterly earnings announcement on Monday, February 15th 2021.
View our earnings forecast for SOC Telemed.

How were SOC Telemed's earnings last quarter?

SOC Telemed, Inc. (NASDAQ:TLMD) posted its earnings results on Monday, November, 16th. The company reported ($0.14) earnings per share for the quarter. The business had revenue of $15.13 million for the quarter.
View SOC Telemed's earnings history.

What price target have analysts set for TLMD?

4 equities research analysts have issued twelve-month target prices for SOC Telemed's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate SOC Telemed's stock price to reach $12.00 in the next year. This suggests a possible upside of 50.8% from the stock's current price.
View analysts' price targets for SOC Telemed or view Wall Street analyst' top-rated stocks.

Who are some of SOC Telemed's key competitors?

Some companies that are related to SOC Telemed include Ontrak (OTRK), Tivity Health (TVTY), American Renal Associates (ARA), HemaCare (HEMA), Viemed Healthcare (VMD), GreenVision Acquisition (GRNV), Emmaus Life Sciences (EMMA), Cryo-Cell International (CCEL), Baudax Bio (BXRX), Pacific Health Care Organization (PFHOD), Caladrius Biosciences (CLBS), Curative Biotechnology (CTYX), BioRestorative Therapies (BRTXQ), BioRestorative Therapies (BRTX) and Pacific Health Care Organization (PFHO).
View all of TLMD's competitors.

Who are SOC Telemed's key executives?

SOC Telemed's management team includes the following people:

Mr. Hai V. Tran, Pres & COO (Age 51, Pay $514.69k)
Mr. Sean Banerjee, Chief Technology Officer (Age 52, Pay $344.65k)
Mr. John W. Kalix, CEO & Director (Age 48)
Ms. Eunice J. Kim, Gen. Counsel & Corp. Sec. (Age 48)
Ms. Meg Hoyecki, VP of Marketing
Mr. James Camic, VP of HR
Dr. Alberto PeÃ±alver, Chief of Psychiatry
Dr. William S. Krimsky, Chief of Critical Care
Dr. Andy Barbash, Chief of Neurology
Dr. R. Jason Hallock M.D., Chief Medical Officer (Age 49)

What is SOC Telemed's stock symbol?

SOC Telemed trades on the NASDAQ under the ticker symbol "TLMD."

How do I buy shares of SOC Telemed?

Shares of TLMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SOC Telemed's stock price today?

One share of TLMD stock can currently be purchased for approximately $7.96.

How big of a company is SOC Telemed?

SOC Telemed has a market capitalization of $713.41 million. SOC Telemed employs 287 workers across the globe.

What is SOC Telemed's official website?

The official website for SOC Telemed is www.soctelemed.com.

How can I contact SOC Telemed?

SOC Telemed's mailing address is 1768 Business Center Drive Suite 100, Reston VA, 20190. The company can be reached via phone at 703-678-2122.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here